Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial

Summary

The purpose of the study is to extend the use of opicapone 25 or 50mg once per day by subjects who participated in the BIA 9-1067-302 clinical trial according form 4a for additional three years.

Timeline

Start

2013-05

Primary completion

2016-05-24

Completion

2016-05-24

Drugs

Indications